Society for Clinical Research Sites Launches the Site Advocacy Group Initiative
The Society for Clinical Research Sites has launched its newest initiative, the Site Advocacy Group, with TransCelerate BioPharma as its SAG partner.
The Society for Clinical Research Sites (SCRS) has launched its newest initiative, the Site Advocacy Group (SAG), with TransCelerate BioPharma as its SAG partner.
The SAG initiative consists of SCRS members representing a broad spectrum of site professionals and clinical research sites who will partner with TransCelerate workstream members to exchange practical feedback on various topics. In return, industry leaders will share with the sites their key priorities and initiatives to elevate the ecosystem. It is hoped that the knowledge gained will help to promote site sustainability, enhance clinical research effectiveness and more closely align the work of the sites and industry across the research ecosystem.
Read the full release here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
